Mr. Vandal has served as our Sr. Vice President of Commercial since June 2014. He has more than 25 years of executive and commercial leadership experience in the pharmaceutical industry. Prior to joining Cara Therapeutics, Eric was the Vice President, Sales and Marketing for Nuvo Research Inc, a specialty pharmaceutical company specializing in topical pain products. At Nuvo Research, Eric built and lead a commercial team of 25 employees in re-launching SYNERA® Patch into the interventional pain physician segment as well as pioneering its efforts to establish SYNERA® Patch in large corporate health care companies.
Prior to joining Nuvo Research, Eric was Senior Director, Marketing for King Pharmaceuticals where he led the company’s hospital business unit. At King Pharmaceuticals, he oversaw the company’s hospital franchises, including their hemostasis portfolio (Thrombin-JMI®) and launched their pain franchise into the hospital segment.
Prior to working at King Pharmaceuticals, Eric was at Alpharma Pharmaceuticals where he was Senior Director, Marketing as well as the Regional Business Director for the Northeast Region. At Alpharma, he was the head of the marketing department that successfully launched the first topical NSAID in the United States, FLECTOR® Patch, and significantly grew the KADIAN® Capsule business.
Eric previously worked for Endo Pharmaceuticals where he took on roles of increasing responsibility within its commercial organization, including leadership over the launch of PERCOCET® line extensions, OPANA® and OPANA® ER franchise as well as FROVA® Tablets.
Eric began his career working in a variety of sales and marketing roles for Schering-Plough and SmithKline Beecham. Eric holds a B.A. in Economics from Harvard University.